Symptom Monitoring in Hemodialysis (NCT05738330)
Comparative Effectiveness of Two Approaches to Symptom Monitoring in Hemodialysis
🩺 Plain-English Summary (8th-Grade Level)
The SMaRRT-HD trial is a cluster randomized trial of symptom monitoring with supported clinician follow-up using the SMaRRT-HD electronic patient reported outcome measure (ePROM) system versus Usual Care. Approximately 2400 patients at up to 36 geographically and racially diverse US hemodialysis clinics will be enrolled. The primary trial hypothesis is that regular symptom patient reported outcome measure (PROM) administration with supported clinician follow-up in dialysis care will reduce suffering and improve outcomes by prompting treatment of unrecognized symptoms, and enhancing patient-care team communication. Clinics randomized to the SMaRRT-HD group will adopt the use of SMaRRT-HD for 12 months. SMaRRT-HD is a symptom monitoring system that includes 1) tablet-based symptom reporting using a PROM and 2) supported clinician follow-up consisting of symptom alerts, guidances for symptom management, and symptom tracking reports that are shared with patients. Dialysis clinics randomized to Usual Care will not adopt SMaRRT-HD or any other trial-driven procedures. Usual Care clinics will monitor symptoms through clinical care interactions with participants and by administering a Health Related Quality of Life survey that includes questions about symptoms.
Who can join: Review the eligibility criteria below.
Location: Fresenius Medical Care — Waltham, Massachusetts
Age range: 18 Years
🧪 Interventions in This Study
- Symptom Monitoring on Renal Replacement Therapy - Hemodialysis (SMaRRT-HD) (BEHAVIORAL)
- Usual Care (BEHAVIORAL)
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (1 Sites)
- Fresenius Medical Care — Waltham, Massachusetts
📞 Contact the Study Coordinator
Phone: (919) 445-6790
Email: Cassandra_Bowman@unc.edu
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in End Stage Kidney Disease
- Immunological Tolerance in Patients With Mismatched Kidney Transplants — Los Angeles, California
- Pain Reduction Using NEurostimulation Study — New York, New York
- Virtual Reality in Hemodialysis to Improve Psychological Well-being — Chicago, Illinois
- Potassium Containing Salt-Substitute in Hemodialysis-Dependent End Stage Kidney Disease — New York, New York
- Moda-flx Hemodialysis System™ Under Professional Care Settings by Trained Individuals and At Home by Participants — San Dimas, California
- Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD) — Decatur, Alabama
Explore by condition: All End Stage Kidney Disease clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.